<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02893904</url>
  </required_header>
  <id_info>
    <org_study_id>BIS and EEG</org_study_id>
    <nct_id>NCT02893904</nct_id>
  </id_info>
  <brief_title>EEG Profiles During General Anesthesia : a Comparative Study Between Sevoflurane and Propofol</brief_title>
  <official_title>Electroencephalographic Profiles During General Anesthesia : a Comparative Study Between Sevoflurane and Propofol.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Armand Trousseau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Club d'Anesthésie-Réanimation Pédiatrique Armand Trousseau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hôpital Armand Trousseau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cerebral pharmacodynamic feedback may help the anesthesiologist to adjust anesthetics
      administration. The BIS, which provides a single number resulting from an algorithm
      calculated from cortical EEG parameters, may play this role.Moreover, halogenated agents and
      propofol may have different EEG effects, which might interfere on measured BIS values.

      The aim of this prospective randomized study was to compare, in steady state conditions, the
      EEG profiles in children anesthetized with sevoflurane (S) or propofol (P) : for both
      anesthetics, the BIS-concentration relationship and raw EEG were analysed at different levels
      of general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children will be prospectively included and randomly assigned in two groups : Propofol (P)
      Group or Sevoflurane (S) Group.

      Steady state periods will be performed at a fixed randomized concentration between 2, 3, 4, 5
      and 6 mcg/ml of stable Ct P concentration in the P group and between 1,2,3,4,5 % of FeS in
      the S group.

      At the end of each steady-state period the BIS value was noted and the relationship between
      BIS and anesthetic concentrations will be studied using non linear regression. For all steady
      state periods, EEG traces will be reviewed to determine the presence of epileptiform signs
      (ES) and spectral EEG signal analysis with fast Fourier transformation (FFT) will be
      performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bispectral profiles</measure>
    <time_frame>The average value of BIS is calculated on the last minute of each ten minutes steady state period .</time_frame>
    <description>For each patient, before surgery and according to the constraints of operating schedule, one or two 10 min steady state periods were performed at a fixed FeS randomized between 1, 2, 3, 4 and 5 % of Sevoflurane in the Sevoflurane group or at a fixed Ct P randomized between 2, 3, 4, 5 and 6 mcg/ml in the propofol group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of epileptiform EEG signs</measure>
    <time_frame>Last minute of each ten minutes steady state period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spectral analysis of EEG signal</measure>
    <time_frame>Last minute of each ten minutes steady state period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>General anesthesia by TCI Propofol and Remifentanil guided by BIS EEG monitoring intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>General anesthesia by Sevoflurane and Remifentanil guided by BIS EEG monitoring intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG monitoring under propofol</intervention_name>
    <description>Steady state concentrations periods of Propofol for EEG data analyzes. Remifentanil was administrated at constant rate in all patients.</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG monitoring under sevoflurane</intervention_name>
    <description>Steady state concentrations periods of Sevoflurane for EEG data analyzes. Remifentanil was administrated at constant rate in all patients.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  from five to eighteen year of age, ASA 1 or 2, scheduled for middle ear surgery

        Exclusion Criteria:

          -  obesity (body mass index &gt; percentile 97); history of cardiac, pulmonary, or renal
             disease; known neurological or neuromuscular disorders; preoperative administration of
             medications known to interfere with the central nervous system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Departement d'anesthesie Hopital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2016</study_first_submitted>
  <study_first_submitted_qc>September 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital Armand Trousseau</investigator_affiliation>
    <investigator_full_name>Pr Isabelle CONSTANT</investigator_full_name>
    <investigator_title>Pr Isabelle CONSTANT</investigator_title>
  </responsible_party>
  <keyword>Propofol</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Bispectral Index</keyword>
  <keyword>Children</keyword>
  <keyword>Electroencephalographic signs</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

